Odonate Therapeutics, Inc. (ODTC)

Odonate Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	39.54	10.72	68.89	157.27	180.46
Short-Term Investments	17.48	37.48	0	0	0
Cash & Cash Equivalents	57.02	48.2	68.89	157.27	180.46
Cash Growth	18.29%	-30.03%	-56.19%	-12.85%	29.78%
Receivables	0	0	6.01	0	0
Other Current Assets	0.07	0.07	0.25	2.61	3.47
Total Current Assets	57.09	48.27	75.15	159.87	183.93
Property, Plant & Equipment	0.39	0.5	3.21	6.3	3.24
Long-Term Investments	21.46	21.59	0.59	0.71	0.71
Other Long-Term Assets	31.52	33.37	0.05	1	0.94
Total Long-Term Assets	53.37	55.46	3.85	8.01	4.9
Total Assets	110.45	103.73	79	167.89	188.83
Accounts Payable	0	0.02	0.29	14.17	15.58
Current Debt	0.5	0.47	0.76	0.66	0.32
Other Current Liabilities	0.01	0.09	14.77	12.25	8.88
Total Current Liabilities	0.51	0.58	15.83	27.07	24.78
Long-Term Debt	0	0	0	4.67	1.75
Other Long-Term Liabilities	1.82	2.3	3.9	0	0
Total Long-Term Liabilities	1.82	2.3	3.9	4.67	1.75
Total Liabilities	2.33	2.88	19.73	31.74	26.53
Total Debt	2.3	2.77	4.67	5.33	2.06
Debt Growth	-16.94%	-40.69%	-12.37%	158.17%	-
Common Stock	0	0.28	0.29	0.37	0.3
Retained Earnings	-384.48	-391.8	-434.74	-366.43	-240.08
Comprehensive Income	0.23	0.08	0	0	0
Shareholders' Equity	108.12	100.85	59.26	136.15	162.3
Total Liabilities and Equity	110.45	103.73	79	167.89	188.83
Net Cash / Debt	54.72	45.44	64.23	151.94	178.4
Net Cash / Debt Growth	20.43%	-29.25%	-57.73%	-14.83%	28.30%
Net Cash Per Share	19.07	15600.23	846.79	2311.74	2946.96
Working Capital	56.58	47.69	59.32	132.8	159.15
Book Value Per Share	37.74	34682.66	781.38	2071.43	2681.05

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.